Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-18-002770
Filing Date
2018-04-13
Accepted
2018-04-13 06:09:08
Documents
9
Period of Report
2018-06-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2235295zpre14a.htm PRE 14A 949678
2 G429299.JPG g429299.jpg GRAPHIC 23328
3 G650180.JPG g650180.jpg GRAPHIC 8714
4 G245976.JPG g245976.jpg GRAPHIC 8525
5 G677153.JPG g677153.jpg GRAPHIC 32369
6 G144310.JPG g144310.jpg GRAPHIC 31749
7 G28372BGI001.GIF g28372bgi001.gif GRAPHIC 121347
8 G28372BII001.GIF g28372bii001.gif GRAPHIC 155763
9 G28372BKI001.GIF g28372bki001.gif GRAPHIC 200597
  Complete submission text file 0001047469-18-002770.txt   1753551
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33497 | Film No.: 18753098
SIC: 2834 Pharmaceutical Preparations